Cancer research

Publications, biological targets, drugs, evidence levels, and clinical trials.

The cancer-research field uses an evidence ladder from cell models to clinical practice. The system gives research orientation; it does not diagnose or pick a treatment.

Signals

• Diffuse Large B-Cell Lymphoma - PMC — Diffuse large B-cell lymphoma
• The Revolution of Targeted Therapies in Thyroid Cancer Treatment: Present and Future Promising Anti-Cancer Drugs — Thyroid cancer
• Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study — NSCLC
• People with lung cancer have more microplastics in their lungs — Lung cancer
• Biotech Catalyst Calendar – Trial Readout Dates by Month – SPZCO — NSCLC
• Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer — Thyroid cancer
• Biomarker-Independent ADC Rina-S Advances to Phase 3 in Endometrial Cancer — Endometrial cancer
• Mount Sinai Study Finds Chemotherapy-Free Treatment Shows Promise for Some Patients With Metastatic Breast Cancer — Breast cancer
• Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology — NSCLC
• New fibroblast state reveals how lung tumors may suppress immune defenses — NSCLC
• Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement‑driven immune‑stromal interactions as a therapeutic target. — Myelofibrosis
• Induction Paclitaxel-Cisplatin-Capecitabine for Nasopharyngeal Carcinoma — Nasopharyngeal carcinoma
• Modern Gastric Cancer Care: From Diagnosis to Treatment — Gastric cancer
• Hemophagocytic lymphohistiocytosis and posterior reversible encephalopathy syndrome during BRAF/MEK inhibitor therapy following immune checkpoint blockade in metastatic melanoma: a case report — Melanoma
• Evaluation of the Effects of Date Palm Leaf Extract (Phoenix dactylifera) on EGFR Gene Expression in the MDA-MB-231 Breast Cancer Cell Line — Breast cancer
• A Novel Therapeutic Approach for High‑Risk and Relapsed/Refractory Neuroblastoma: Dinutuximab Beta — Neuroblastoma
• ctDNA Detects Postsurgical Merkel Cell Recurrence — Merkel cell carcinoma
• The 25th Anniversary of Imatinib and the Evolution of Small Molecule Inhibitors — Breast cancer
• Phytochemicals Targeting Inflammatory Signaling Pathways to Combat Gastric Cancer — Gastric cancer
• Hodgkin Lymphoma – Brown Health Cancer Institute — Hodgkin lymphoma